Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.


The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page


My NCBI Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1979 1
1980 1
1981 1
1982 3
1983 1
1984 8
1985 5
1986 4
1987 3
1988 9
1989 3
1990 14
1991 15
1992 16
1993 15
1994 34
1995 30
1996 36
1997 33
1998 27
1999 45
2000 52
2001 83
2002 79
2003 107
2004 119
2005 143
2006 144
2007 197
2008 237
2009 266
2010 312
2011 374
2012 474
2013 512
2014 594
2015 660
2016 661
2017 742
2018 906
2019 1050
2020 1258
2021 1298
2022 1505
2023 1596
2024 1033

Text availability

Article attribute

Article type

Publication date

Search Results

13,181 results

Results by year

Filters applied: . Clear all
Page 1
International Myeloma Working Group immunotherapy committee consensus guidelines and recommendations for optimal use of T-cell-engaging bispecific antibodies in multiple myeloma.
Rodriguez-Otero P, Usmani S, Cohen AD, van de Donk NWCJ, Leleu X, Gállego Pérez-Larraya J, Manier S, Nooka AK, Mateos MV, Einsele H, Minnema M, Cavo M, Derman BA, Puig N, Gay F, Ho PJ, Chng WJ, Kastritis E, Gahrton G, Weisel K, Nagarajan C, Schjesvold F, Mikhael J, Costa L, Raje NS, Zamagni E, Hájek R, Weinhold N, Yong K, Ye JC, Sidhana S, Merlini G, Martin T, Lin Y, Chari A, Popat R, Kaufman JL; International Myeloma Working Group. Rodriguez-Otero P, et al. Among authors: ye jc. Lancet Oncol. 2024 May;25(5):e205-e216. doi: 10.1016/S1470-2045(24)00043-3. Lancet Oncol. 2024. PMID: 38697166 Review.
Senescent CAFs Mediate Immunosuppression and Drive Breast Cancer Progression.
Ye J, Baer JM, Faget DV, Morikis VA, Ren Q, Melam A, Delgado AP, Luo X, Bagchi SM, Belle JI, Campos E, Friedman M, Veis DJ, Knudsen ES, Witkiewicz AK, Powers S, Longmore GD, DeNardo DG, Stewart SA. Ye J, et al. Cancer Discov. 2024 Jul 1;14(7):1302-1323. doi: 10.1158/2159-8290.CD-23-0426. Cancer Discov. 2024. PMID: 38683161
Updated mechanisms of MASLD pathogenesis.
Li Y, Yang P, Ye J, Xu Q, Wu J, Wang Y. Li Y, et al. Among authors: ye j. Lipids Health Dis. 2024 Apr 22;23(1):117. doi: 10.1186/s12944-024-02108-x. Lipids Health Dis. 2024. PMID: 38649999 Free PMC article. Review.
Targeting PRAME for acute myeloid leukemia therapy.
Yang J, Chen M, Ye J, Ma H. Yang J, et al. Among authors: ye j. Front Immunol. 2024 Mar 26;15:1378277. doi: 10.3389/fimmu.2024.1378277. eCollection 2024. Front Immunol. 2024. PMID: 38596687 Free PMC article. Review.
Promiscuous G-protein activation by the calcium-sensing receptor.
Zuo H, Park J, Frangaj A, Ye J, Lu G, Manning JJ, Asher WB, Lu Z, Hu GB, Wang L, Mendez J, Eng E, Zhang Z, Lin X, Grassucci R, Hendrickson WA, Clarke OB, Javitch JA, Conigrave AD, Fan QR. Zuo H, et al. Among authors: ye j. Nature. 2024 May;629(8011):481-488. doi: 10.1038/s41586-024-07331-1. Epub 2024 Apr 17. Nature. 2024. PMID: 38632411
Nanodrug Delivery Systems in Antitumor Immunotherapy.
Guo Z, Ye J, Cheng X, Wang T, Zhang Y, Yang K, Du S, Li P. Guo Z, et al. Among authors: ye j. Biomater Res. 2024 Apr 25;28:0015. doi: 10.34133/bmr.0015. eCollection 2024. Biomater Res. 2024. PMID: 38840653 Free PMC article. Review.
13,181 results
You have reached the last available page of results. Please see the User Guide for more information.